Related Experiment Video
Updated: Feb 3, 2026

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
Impact of Preoperative Diuretics Treatment on Long-Term Clinical Outcomes After Transcatheter Aortic Valve
Shun Hirosawa1, Hiroaki Yokoyama1, Ken Yamazaki1
1Department of Cardiology, Hirosaki University Graduate School of Medicine.
Insights
Preoperative diuretic use in severe aortic stenosis patients undergoing transcatheter aortic valve implantation is linked to worse long-term outcomes. This study found higher mortality rates in patients treated with diuretics before TAVI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Diuretics are commonly used to manage congestive symptoms in severe aortic stenosis (AS).
- The impact of pre-TAVI diuretic treatment on long-term outcomes in AS patients remains under investigation.
- Transcatheter aortic valve implantation (TAVI) is a key treatment for severe AS.
Purpose of the Study:
- To evaluate the effect of preprocedural diuretic treatment on clinical outcomes in patients undergoing TAVI.
- To determine if pre-TAVI diuretic use is an independent predictor of mortality after TAVI.
Main Methods:
- Prospective enrollment of 4,903 consecutive AS patients undergoing TAVI across 7 Japanese hospitals (April 2010 - June 2024).
- Patients were categorized into Diuretics (n=2,073) and Non-Diuretics (n=2,830) groups based on pre-TAVI treatment.
- Propensity score matching was employed to adjust for confounding factors and assess mortality outcomes over a median 2.1-year follow-up.
Main Results:
- The Diuretics group exhibited higher rates of comorbidities, poorer NYHA classification, reduced LVEF, and impaired renal function.
- Patients receiving preprocedural diuretics had significantly worse all-cause (38% vs. 26%) and cardiovascular mortality (18% vs. 10%) compared to the Non-Diuretics group (P < 0.001).
- Post-propensity score matching, pre-TAVI diuretic treatment remained an independent predictor of worse all-cause (HR: 1.29) and cardiovascular mortality (HR: 1.61).
Conclusions:
- Approximately 40% of AS patients undergoing TAVI received preoperative diuretics.
- Preprocedural diuretic treatment is associated with significantly worse long-term all-cause and cardiovascular mortality after TAVI.
- Preoperative diuretic use is an independent predictor of adverse outcomes following TAVI in severe AS patients.
Abstract:
Diuretics are used to relieve congestive symptoms in patients with severe aortic stenosis (AS). However, the effect of preprocedural diuretic treatment on long-term outcomes in AS patients who undergoing transcatheter aortic valve implantation (TAVI) remains unclear. We prospectively enrolled 4,903 consecutive AS patients who underwent TAVI in 7 Japanese hospitals between April 2010 and June 2024 and evaluated the effect of preprocedural diuretics treatment on clinical outcomes. Patients were divided into 2 groups as follows: the Diuretics group, who received diuretic treatment before TAVI (n = 2,073), and the Non-Diuretics group without diuretic treatment (n = 2,830). The median observation period was 2.1 years. The Diuretics group was older and had higher surgical risk scores and more comorbidities, including prior myocardial infarction, atrial fibrillation/flutter, and peripheral artery disease. The Diuretics group included more patients with New York Heart Association (NYHA) classification III/IV, lower left ventricular ejection fraction, and reduced renal function. They had significantly worse all-cause and cardiovascular mortality than those in the Non-Diuretics group (38% versus 26% and 18% versus 10%, respectively; P < 0.001 by log-rank test). After propensity score matching to minimize the influence of confounding factors, preoperative diuretic treatment was associated with worse all-cause mortality (hazard ratio [HR]: 1.29, 95% confidence interval [CI]: 1.06-1.58, P = 0.012) and cardiovascular mortality (HR: 1.61, 95%CI: 1.15-2.26, P = 0.006). Two fifths of AS patients who undergoing TAVI received preoperative diuretics, and those patients had worse all-cause and cardiovascular mortality. Preprocedural diuretic treatment was an independent predictor of all-cause and cardiovascular mortality after TAVI.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Predicting Reaction Outcomes
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Diuretics
Impact of Groups on Groups

